Before treating addiction, clinicians need to understand its underlying causes and how if affects the brain on a biological level. Too often clinicians and stakeholders view substance use disorder as a moral failing or a character flaw instead of a health condition. By analyzing the science behind addiction, we can start to bridge the gap between research and how we talk about addiction. Not only patients and families, but health care providers, educators, and criminal justice stakeholders need to view this condition as a brain disease in order to proliferate empathy and compassion.
A common preconceived notion pertaining to substance use disorder is that an individual typically needs to hit “rock bottom” before getting the help they need. This idea can be detrimental as earlier intervention is highly beneficial and addiction only worsens with time. In addition to changing perspectives surround addiction, clinicians and other stakeholders need to focus on dismantling the barriers to MAT access. Any additional roadblocks to treatment only lessen the likelihood of recovery.
In this CME Snack, Jessica Nickel, founder of the Addiction Policy Forum, and Dr. Mark Gold focus on community-based strategies to provide an effective care settings for those dealing with substance use disorder.
At the end of this CME/CE activity, participants should be able to integrate in practice concepts from novel programs in the community to address opioid overdose to treat patients with opioid use disorder (OUD).
The following learning objectives pertain only to those requesting CNE or CPE credit: Outline concepts from novel programs in the community to address opioid overdose and treat patients with opioid use disorder (OUD).
Supported by CME Outfitters, LLC.
Physicians, physician assistants, nurse practitioners, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Gold has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-19-030-H01-P.
Call us at 877.CME.PROS (877.263.7767).